Western Wealth Management’s Aurinia Pharmaceuticals AUPH Stock Holding History

Western Wealth Management’s Portfolio AUPH Stock Details AUPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$287K	Sell	16,917 -3,400	-17%	-$54.3K	0.01%	842
2026 Q1	$301K	Hold	20,317	–	–	0.01%	799
2025 Q4	$324K	Hold	20,317	–	–	0.01%	636
2025 Q3	$225K	Buy	20,317 +317	+2%	+$3.46K	0.01%	698
2025 Q2	$169K	Hold	20,000	–	–	0.01%	711
2025 Q1	$161K	Hold	20,000	–	–	0.01%	662
2024 Q4	$180K	Hold	20,000	–	–	0.01%	737
2024 Q3	$147K	Buy	+20,000	New	+$124K	0.01%	727
2022 Q3	–	Sell	-26,650	Closed	-$269K	–	810
2022 Q2	$269K	Sell	26,650 -600	-2%	-$6.71K	0.02%	644
2022 Q1	$338K	Buy	+27,250	New	+$421K	0.02%	635

Other funds holding AUPH

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Western Wealth Management's AUPH Position: Q2 2026 in Review

Western Wealth Management reduced its Aurinia Pharmaceuticals (AUPH) stake by 17% in Q2 2026, selling an estimated $54.3K and leaving 16,917 shares worth $287K. The position accounts for 0.01% of the portfolio, ranked #842.

Western Wealth Management first reported a position in AUPH in Q1 2022 and has held it in 10 quarters since. The position peaked at $338K in Q1 2022. 283 funds tracked by Wall St. Rank hold AUPH as of Q2 2026.

Western Wealth Management held 16,917 shares of Aurinia Pharmaceuticals worth $287K as of Q2 2026.
Western Wealth Management sold 3,400 Aurinia Pharmaceuticals shares in Q2 2026, an estimated $54.3K.
Aurinia Pharmaceuticals made up 0.01% of Western Wealth Management's portfolio in Q2 2026, its #842 holding.
Western Wealth Management first reported a position in Aurinia Pharmaceuticals in Q1 2022 and has held it in 10 quarters since.
Western Wealth Management's Aurinia Pharmaceuticals position peaked at $338K in Q1 2022.
283 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q2 2026.

Based on Western Wealth Management's 13F filing for Q2 2026, filed 14 Aug 2026.